The Department of Health and Human Services is ending a $766 million contract with the vaccine company Moderna to develop an ...

As bird flu sweeps across US poultry and cattle farms, researchers are racing to find ways to contain the outbreaks before ...

The bird flu virus remains a wild card that continues to threaten U.S. poultry and egg supplies while upping the ante with risk to human health.

Health Secretary Robert F. Kennedy Jr. has repeatedly questioned the safety of mRNA technology, which is used in the ...

The US has withdrawn $766 million in funding for Moderna's H5N1 vaccine amid a severe bird flu outbreak. This raises concerns ...

Since bird flu was first discovered in U.S. cattle last year, the virus has spread to more than 1,000 herds across the ...

The department cited Moderna’s use of the messenger RNA technology, which it said “remains under-tested,” for the ...

Over the past three years, avian influenza (H5N1) has spread around the U.S. and affected many species of birds and mammals, ...

MRNA technology is already used in Moderna’s and Pfizer/BioNTech’s currently licensed COVID-19 vaccines, which have been found to be safe and effective.

On Wednesday, as news broke that the Trump administration was reneging on the contract, Moderna reported positive results from an early trial of a vaccine targeting H5 influenza viruses. In a ...

STORY: Bird flu is spreading through U.S. poultry flocks and cattle herds.It’s infected 70 people in the country over the ...

Highly pathogenic avian influenza viruses like H5N1, H5N6, and H7N9 pose an evolving global threat due to their capacity to ...